BRIEF-GW Pharmaceuticals Reacquires Full Rights To Develop And Commercialize Sativex In U.S. By: Reuters: Company News December 13, 2017 at 07:16 AM EST * GW PHARMACEUTICALS REACQUIRES FULL RIGHTS TO DEVELOP AND COMMERCIALIZE SATIVEX® IN U.S. Read More >> Related Stocks: Gw Pharmaceuticals